Ana Paula Candiota

Dr. Candiota (b. 1971, Rio Grande do Sul, Brazil). Presently working in the biomedical applications of nuclear magnetic resonance (NMR/MRI/MRS/MRSI), with a special focus in the evaluation of glial brain tumours from preclinical mice models. Main efforts are actually devoted to the noninvasive therapy response follow-up in preclinical glioblastoma. For this, MRSI- based molecular imaging techniques and pattern recognition strategies are being applied to generate nosological maps of therapy response with translational potential. Finally, besides conventional therapeutic agents, novel therapeutic strategies are also being evaluated in preclinical glioblastoma.

Dr. Candiota graduated (BSc) in Pharmacy in 1997 (UCPel, Brazil). Awarded three times with stage grants to Spain from the Agencia Española de Cooperación Internacional (AECI) between 1997 and 1999. PhD in Bioquímica, biologia molecular i biomedicina awarded at Universitat Autònoma de Barcelona, Spain in 2005. Since 2007, she is a permanent researcher of Centro de Investigación Biomédica en Red (CIBER) Bioingeniería, Biomateriales y Nanomedicina (http://www.ciber-bbn.es/). She is also Profesor Asociado at Universitat Autònoma de Barcelona, at the Biology BSc and the Master of Nanotechnology .